Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  European Journal of Cancer and Clinical Oncology

• Publication date

  1984-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0277-5379(84)90223-2PMID 6540184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antitumor effects of rhodium(I), iridium(I) and ruthenium(II) complexes in comparison with cis-dichlorodiammino platinum(II) in mice bearing Lewis lung carcinoma.

  1983cited by this paper
• Organo-platinum complexes as antitumor agents (review).

  1982cited by this paper
• Antitumor activity and toxicity of cisplatin analogs.

  1982cited by this paper
• Organo-platinum complexes as antitumor agents (review).

  1982cited by this paper
• Cisplatin (cis-diamminedichloroplatinum II).

  1979cited by this paper
• Antitumor action of rhodium (I) and iridium (I) complexes.

  1978cited by this paper
• Fractional incorporation of [3H]thymidine and DNA specific activity as assays of inhibition of tumour growth.

  1977cited by this paper
• Antitumor action of two rhodium and ruthenium complexes in comparison with cis-diamminedichloroplatinum(II).

  1977cited by this paper
• Structure and activity relationships of platinum complexes with anti-tumour activity.

  1975cited by this paper
• Antitumour action of planar, organometallic rhodium(I) complexes.

  1974cited by this paper
• Inhibition of bacterial growth and nucleic acids synthesis by planar complexes of rhodium (I)

  1974cited by this paper
• Transition metal complexes in cancer chemotherapy

  1974cited by this paper
• Platinum Compounds: a New Class of Potent Antitumour Agents

  1969cited by this paper
• Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode

  1965cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Novel Ruthenacarborane–NSAID Conjugates

  2025cites this paper
• New Ru(III) 2,6-Bis(2-benzimidazolyl)Pyridine Complexes Bearing p-sub-Benzyl Thiosemicarbazones Schiff Base: Synthesis, Characterization, DNA Binding and Anti-cancer Activity.

  2025cites this paper
• Exploring the coordination chemistry of ruthenium complexes with lysozymes: structural and in-solution studies

  2024cites this paper
• Synthesis, structure, cytotoxicity, photodynamic reactivities and molecular simulation studies of three [RuNO(Qn)(Pro)Cl] isomeric complexes

  2024cites this paper
• The Effect of Photosensitizer Metalation Incorporated into Arene–Ruthenium Assemblies on Prostate Cancer

  2023cites this paper
• A Ru(II)-Strained Complex with 2,9-Diphenyl-1,10-phenanthroline Ligand Induces Selective Photoactivatable Chemotherapeutic Activity on Human Alveolar Carcinoma Cells via Apoptosis

  2023cites this paper
• Recent Advances in Zinc Oxide Nanoparticles (ZnO NPs) for Cancer Diagnosis, Target Drug Delivery, and Treatment

  2021cites this paper
• Synthesis, Characterization, and Evaluation of Antitumor Potential in MCF-7 Cells of Ruthenium-Derived Compounds

  2020cites this paper
• Synthesis, spectroscopic characterization and computational study of Ru(II)/DMSO complexes with monocoordinated carbazate ligands

  2020cites this paper
• Synthesis, structure and biological evaluation of ruthenium(III) complexes of triazolopyrimidines with anticancer properties

  2019cites this paper
• Schiff Bases and Their Metal Complexes as Potential Anticancer Candidates: A Review of Recent Works.

  2019cites this paper
• Shedding Light on the Hydrolysis Mechanism of cis, trans-[Ru(dmso)4Cl2] Complexes and Their Interactions with DNA-A Computational Perspective.

  2019cites this paper
• Ruthenium carbonyl containing 4-pyrones as potent anticancer agents

  2018cites this paper
• Synthesis and characterization of triruthenium carbonyl incorporating 4-pyridones as potential antitumor agents

  2018cites this paper
• Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.

  2018cites this paper
• A Review of Ruthenium Complexes Activities on Breast Cancer Cells.

  2017cites this paper
• Colorectal Cancer Chemotherapy: The Evolution of Treatment and New Approaches.

  2017cites this paper
• Cytogenotoxic effects of two potential anticancer Ruthenium(III) Schiff Bases complexes

  2016cites this paper
• Radiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes

  2016cites this paper
• Apoptosis of Bel-7402 human hepatoma cells induced by a ruthenium(II) complex coordinated by cordycepin through the p53 pathway.

  2015cites this paper
• Mode of action of tin-based anti-proliferative agents: Biological studies of organotin(IV) derivatives of fatty acids.

  2015cites this paper
• Partha Roy , Snehasish Das Metal-Based Anticancer Agents : In vitro DNA Binding , Cleavage and Cytotoxicity S

  2014cites this paper
• Metal-Based Anticancer Agents: In vitro DNA Binding, Cleavage and Cytotoxicity

  2014cites this paper
• Interaction of 5 ′-GuanosineMonophosphate with Organotin ( IV ) Moieties : Synthesis , Structural Characterization , and Anti-Inflammatory Activity

  2014cites this paper
• In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Breast Cancer

  2014cites this paper
• INTERAKCIJA KOMPLEKSA PLATINE I RUTENIJUMA SA PANKREASNOM FOSFOLIPAZOM A 2 I FOSFOLIPIDIMA

  2013cites this paper
• Solvolysis and cytotoxicity of dinuclear ruthenium(II)-2,2′-bipyridine complexes with various bridged-ligands

  2013cites this paper
• Reactivity Studies of [RuX2(Me2SO)4] (X = Cl, Br or I) With Imidazoles, Pryazoles, and Substituted Imidazoles/Pyrazoles

  2012cites this paper
• Interaction of 5′-Guanosine Monophosphate with Organotin(IV) Moieties: Synthesis, Structural Characterization, and Anti-Inflammatory Activity

  2012influential citation
• New applications of old metal-binding drugs in the treatment of human cancer.

  2012cites this paper
• Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells.

  2012cites this paper
• Interaction of organotin(IV) moieties with nucleic acid constituent: Synthesis, structural characterization and anti-inflammatory activity of tri-i-propyltin(IV) and diorganotin(IV) derivatives of guanosine

  2011cites this paper
• New Ru(II)–DMSO complexes of ON/SN chelates: Synthesis, behavior of Schiff bases towards hydrolytic cleavage of CN bond, electrochemistry and biological activities

  2010cites this paper
• The Ruthenium Complex cis-(Dichloro)tetraammineruthenium(III) Chloride Presents Selective Cytotoxicity Against Murine B Cell Lymphoma (A-20), Murine Ascitic Sarcoma 180 (S-180), Human Breast Adenocarcinoma (SK-BR-3), and Human T Cell Leukemia (Jurkat) Tumor Cell Lines

  2010cites this paper
• Ruthenium-based chemotherapeutics: are they ready for prime time?

  2010cites this paper
• Ru(DMSO)4Cl2 nano-aggregated Nafion membrane modified electrode for simultaneous electrochemical detection of hypoxanthine, xanthine and uric acid

  2010cites this paper
• Syntheses of ruthenium(II)-4,4′-biimidazole complexes and their potential anti-tumour activity

  2010cites this paper
• Ru(II)–DMSO complexes containing aromatic and heterocyclic acid hydrazides: Structure, electrochemistry and biological activity

  2009cites this paper
• New Ru(II)–dmso complexes with heterocyclic hydrazone ligands towards cancer chemotherapy

  2008cites this paper
• Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursors.

  2008cites this paper
• Dimethyl sulfoxide ruthenium(II) complexes of thiosemicarbazones and semicarbazone: Synthesis, characterization and biological studies

  2008cites this paper
• Photochemistry of trans‐ and cis‐[RuCl2(dmso)4] in Aqueous and Nonaqueous Solutions

  2007cites this paper
• Analysis in vivo of antitumor activity, cytotoxicity and Interaction between plasmid DNA and the cis-dichloro-tetra-amine-ruthenium(III) chloride.

  2007cites this paper
• Synthesis, structure and properties of ruthenium(II) complexes with quinolinedione derivatives as chelate ligands : Crystal structure of [Ru (CO )2Cl2 (6 -methoxybenzo [g ]quinoline -5,10 -dione )]

  2007cites this paper
• Ruthenium complexes as anticancer agents.

  2006cites this paper
• Synthesis and anticancer activity of certain mononuclear Ru (II) Complexes

  2006cites this paper
• Study on the interactions between anti-tumor metal complexes and mononucleotides using trans-[en2Os(η2-H2)(CF3SO3)](CF3SO3) as a 1H NMR probe in a competitive mode

  2005cites this paper
• Binding of transition metal complexes to guanine and guanine–cytosine: hydrogen bonding and covalent effects

  2005cites this paper
• Synthesis and pharmacological activities of some mononuclear Ru(II) complexes.

  2005cites this paper
• Light-induced anticancer activity of [RuCl2(DMSO)4] complexes.

  2005cites this paper
• Complexes of metals other than platinum as antitumour agents

  2004cites this paper
• Antineoplastic and Antibacterial Activity of some Mononuclear Ru(II) Complexes

  2004cites this paper
• A Phase I and Pharmacological Study with Imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

  2004cites this paper
• Synthesis of ruthenium(II) monosubstituted squarates: 1. Procedural considerations ☆

  2004cites this paper
• Mechanistic information on the reaction of cis- and trans-[RuCl2(DMSO)4] with d(T2GGT2) derived from MALDI-TOF and HPLC studies.

  2004cites this paper
• Synthesis of ruthenium(II) monosubstituted squarates: 2. Single crystal structures of fac-[Ru(Cl)(dmso)3(H2O)(L)] · xH2O (L=anisole-, anilino-squarate) and fac-[Ru({C6H5}2NC4O3)(Cl)(dmso)3(H2O)] · C4H8O ☆

  2004cites this paper
• The synthesis, structural characterization, and in vitro anti-cancer activity of chloro( p -cymene) complexes of ruthenium(II) containing a disulfoxide ligand

  2003cites this paper
• Study of the coordination of amino acids with metals using [trans-en2Os(eta2-H2)L]2+ as a 1H NMR probe.

  2002cites this paper
• Rhodium and its compounds as potential agents in cancer treatment.

  2002cites this paper
• Study on the amount of binding of anti-tumor metal complexes to different target sites of dGMP using trans-[en(2)Os(eta2-H(2))(CF(3)SO(3))](CF(3)SO(3)) in a competitive mode.

  2002cites this paper
• Study on the amount of binding of anti-tumor metal complexes to different target sites of dGMP using trans-[en2Os(η2-H2)(CF3SO3)](CF3SO3) in a competitive mode

  2002cites this paper
• Modification of natural, double-helical DNA by antitumor cis- and trans-[Cl(2)(Me(2)SO(4))(4)Ru] in cell-free media.

  2000cites this paper
• Ruthenium-based compounds and tumour growth control (review).

  2000cites this paper
• Sensitive spectrofluorimetric determination of ruthenium at nanotrace levels using 2-(α-pyridyl) thioquinaldinamide [PTQA]

  1999cites this paper
• In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin.

  1999cites this paper
• Sensitive spectrofluorimetric determination of ruthenium at nanotrace levels using 2-(alpha-pyridyl) thioquinaldinamide [PTQA].

  1999cites this paper
• Sulfoxide Ruthenium Complexes: Non-Toxic Tools for the Selective Treatment of Solid Tumour Metastases

  1999cites this paper
• Comparison of the reactivity of cis-[RuCl2(DMSO)4] and trans-[RuCl2(DMSO)4] towards nucleosides

  1998cites this paper
• Modification of cell cycle and viability of TLX5 lymphoma in vitro by sulfoxide-ruthenium compounds and cisplatin detected by flow cytometry.

  1998cites this paper
• Binding sites of cis-RuIICl2(DMSO)4 to mononucleotides: 1H and 31P NMR evidence

  1997cites this paper
• [Ru2II(ttha)(H2O)2]2− is a rapid No scavenger (ttha6− = triethylenetetraminehexaacetate)

  1997cites this paper
• Interactions of metallopharmaceuticals with DNA.

  1996cites this paper
• Inorganic Anticancer Agents: Their Chemistry and Antitumor Properties

  1995cites this paper
• Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition.

  1995cites this paper
• Response of MCa Mammary Carcinoma to Cisplatin and to Na[trans-RuCl4(DMSO)Im]

  1994cites this paper
• Synthesis and characterization of ruthenium(II) complexes of 5-hydroxyflavones

  1994cites this paper
• Ruthenium compounds in cancer therapy

  1994cites this paper
• Antimetastatic action and toxicity on healthy tissues of Na[trans-RuCl4(DMSO)Im] in the mouse

  1994cites this paper
• Organometallic titanium, vanadium, niobium, molybdenum and rhenium complexes — early transition metal antitumour drugs

  1994cites this paper
• Metal Compounds in Cancer Therapy

  1994influential citation
• Effects of some ruthenium chelates on MCa mammary carcinoma and on TLX5 lymphoma in mice.

  1993cites this paper
• Synthesis and characterization of two new classes of ruthenium(III)-sulfoxide complexes with nitrogen donor ligands (L): Na[trans-RuCl4(R2SO)(L)] and mer, cis-RuCl3(R2SO)(R2SO)(L). The crystal structure of Na[trans-RuCl4(DMSO)(NH3)] · 2DMSO, Na[trans-RuCl4(DMSO)(Im)] · H2O, Me2CO (Im = imidazole) an

  1993cites this paper
• Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline.

  1993cites this paper
• Effects of the Ru(III) complexes [mer-RuCl3(DMSO)2Im]degrees and Na[trans-RuCl4(DMSO)Im] on solid mouse tumors.

  1992cites this paper
• Na[trans-RuCl4(DMSO)Im], a metal complex of ruthenium with antimetastatic properties

  1992cites this paper
• Ruthenium(II)-dimethyl sulfoxide complexes with nitrogen ligands: synthesis, characterization and solution chemistry. The crystal structures of cis,fac-RuCl2(DMSO)3(NH3) and trans,cis,cis-RuCl2(DMSO)2(NH3)2·H2O

  1991cites this paper
• Interaction of RuCl2 (dimethylsulphoxide)4 isomers with DNA.

  1991cites this paper
• Cancer chemotherapy involving platinum and other platinum group complexes.

  1991cites this paper
• Reaction of the octahedral antitumor complex trans-RuCl2 (DMSO)4 with 2'deoxyguanosine.

  1991cites this paper
• Metal complexes of ruthenium: a potential class of selective anticancer drugs.

  1991cites this paper
• Antineoplastic effect of mer-trichlorobisdimethylsulphoxideaminorutheniumIII against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4].

  1991cites this paper
• The Role of Non-Platinum Complexes in Cancer Therapy

  1990cites this paper
• Metal Complexes as Antitumour Agents

  1990cites this paper
• New tumor-inhibiting metal complexes.

  1990cites this paper
• Metal compounds in cancer chemotherapy

  1990cites this paper
• Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in the Lewis lung carcinoma system.

  1989cites this paper
• The chemical and biochemical consequences of the binding of the antitumour drug cisplatin and other platinum group metal complexes to DNA

  1989cites this paper
• Antitumor Activity of Bis[Bis(Diphenylphosphino)Alkane and Alkene] Group VIII Metal Complexes

  1989cites this paper
• Effects of trans-RuCl2 (DMSO)4 on B16 melanoma in mice.

  1989cites this paper
• Antitumour Activity of Metal Complexes

  1989cites this paper